Logo image of DCBO.CA

DOCEBO INC (DCBO.CA) Stock Fundamental Analysis

TSX:DCBO - Toronto Stock Exchange - CA25609L1058 - Common Stock - Currency: CAD

43.18  -0.58 (-1.33%)

Fundamental Rating

6

We assign a fundamental rating of 6 out of 10 to DCBO. DCBO was compared to 63 industry peers in the Software industry. While DCBO has a great health rating, its profitability is only average at the moment. DCBO is growing strongly while it is still valued neutral. This is a good combination! These ratings would make DCBO suitable for growth investing!


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

In the past year DCBO was profitable.
DCBO had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: DCBO reported negative net income in multiple years.
DCBO had a positive operating cash flow in 4 of the past 5 years.
DCBO.CA Yearly Net Income VS EBIT VS OCF VS FCFDCBO.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M

1.2 Ratios

Looking at the Return On Assets, with a value of 14.02%, DCBO belongs to the top of the industry, outperforming 92.06% of the companies in the same industry.
With an excellent Return On Equity value of 46.29%, DCBO belongs to the best of the industry, outperforming 93.65% of the companies in the same industry.
The Return On Invested Capital of DCBO (17.84%) is better than 90.48% of its industry peers.
Industry RankSector Rank
ROA 14.02%
ROE 46.29%
ROIC 17.84%
ROA(3y)6.1%
ROA(5y)2.04%
ROE(3y)18.51%
ROE(5y)8.92%
ROIC(3y)N/A
ROIC(5y)N/A
DCBO.CA Yearly ROA, ROE, ROICDCBO.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 100 150

1.3 Margins

DCBO's Profit Margin of 12.32% is amongst the best of the industry. DCBO outperforms 84.13% of its industry peers.
DCBO has a Operating Margin of 8.72%. This is in the better half of the industry: DCBO outperforms 71.43% of its industry peers.
DCBO's Gross Margin of 80.96% is amongst the best of the industry. DCBO outperforms 87.30% of its industry peers.
In the last couple of years the Gross Margin of DCBO has remained more or less at the same level.
Industry RankSector Rank
OM 8.72%
PM (TTM) 12.32%
GM 80.96%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.38%
GM growth 5Y0.22%
DCBO.CA Yearly Profit, Operating, Gross MarginsDCBO.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 60 80

7

2. Health

2.1 Basic Checks

DCBO has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
The number of shares outstanding for DCBO remains at a similar level compared to 1 year ago.
DCBO has more shares outstanding than it did 5 years ago.
The debt/assets ratio for DCBO has been reduced compared to a year ago.
DCBO.CA Yearly Shares OutstandingDCBO.CA Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
DCBO.CA Yearly Total Debt VS Total AssetsDCBO.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

2.2 Solvency

An Altman-Z score of 4.35 indicates that DCBO is not in any danger for bankruptcy at the moment.
With a decent Altman-Z score value of 4.35, DCBO is doing good in the industry, outperforming 69.84% of the companies in the same industry.
The Debt to FCF ratio of DCBO is 0.05, which is an excellent value as it means it would take DCBO, only 0.05 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of DCBO (0.05) is better than 93.65% of its industry peers.
A Debt/Equity ratio of 0.00 indicates that DCBO is not too dependend on debt financing.
With an excellent Debt to Equity ratio value of 0.00, DCBO belongs to the best of the industry, outperforming 85.71% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0.05
Altman-Z 4.35
ROIC/WACC1.93
WACC9.26%
DCBO.CA Yearly LT Debt VS Equity VS FCFDCBO.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M 200M

2.3 Liquidity

DCBO has a Current Ratio of 1.20. This is a normal value and indicates that DCBO is financially healthy and should not expect problems in meeting its short term obligations.
DCBO has a Current ratio (1.20) which is comparable to the rest of the industry.
DCBO has a Quick Ratio of 1.20. This is a normal value and indicates that DCBO is financially healthy and should not expect problems in meeting its short term obligations.
DCBO has a Quick ratio of 1.20. This is comparable to the rest of the industry: DCBO outperforms 55.56% of its industry peers.
Industry RankSector Rank
Current Ratio 1.2
Quick Ratio 1.2
DCBO.CA Yearly Current Assets VS Current LiabilitesDCBO.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

8

3. Growth

3.1 Past

DCBO shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 855.56%, which is quite impressive.
DCBO shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 19.96%.
Measured over the past years, DCBO shows a very strong growth in Revenue. The Revenue has been growing by 39.25% on average per year.
EPS 1Y (TTM)855.56%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%280%
Revenue 1Y (TTM)19.96%
Revenue growth 3Y27.67%
Revenue growth 5Y39.25%
Sales Q2Q%15.75%

3.2 Future

DCBO is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 27.76% yearly.
The Revenue is expected to grow by 24.94% on average over the next years. This is a very strong growth
EPS Next Y39.51%
EPS Next 2Y29.84%
EPS Next 3Y21.71%
EPS Next 5Y27.76%
Revenue Next Year11.76%
Revenue Next 2Y12.58%
Revenue Next 3Y25.18%
Revenue Next 5Y24.94%

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
DCBO.CA Yearly Revenue VS EstimatesDCBO.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 200M 400M 600M 800M
DCBO.CA Yearly EPS VS EstimatesDCBO.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 1 2 3

5

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 36.29, DCBO can be considered very expensive at the moment.
Based on the Price/Earnings ratio, DCBO is valued a bit cheaper than the industry average as 73.02% of the companies are valued more expensively.
DCBO's Price/Earnings ratio indicates a valuation a bit more expensive than the S&P500 average which is at 28.88.
The Price/Forward Earnings ratio is 26.02, which means the current valuation is very expensive for DCBO.
82.54% of the companies in the same industry are more expensive than DCBO, based on the Price/Forward Earnings ratio.
When comparing the Price/Forward Earnings ratio of DCBO to the average of the S&P500 Index (21.20), we can say DCBO is valued slightly more expensively.
Industry RankSector Rank
PE 36.29
Fwd PE 26.02
DCBO.CA Price Earnings VS Forward Price EarningsDCBO.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

The rest of the industry has a similar Enterprise Value to EBITDA ratio as DCBO.
69.84% of the companies in the same industry are more expensive than DCBO, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 33.45
EV/EBITDA 37.94
DCBO.CA Per share dataDCBO.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
DCBO has a very decent profitability rating, which may justify a higher PE ratio.
A more expensive valuation may be justified as DCBO's earnings are expected to grow with 21.71% in the coming years.
PEG (NY)0.92
PEG (5Y)N/A
EPS Next 2Y29.84%
EPS Next 3Y21.71%

0

5. Dividend

5.1 Amount

No dividends for DCBO!.
Industry RankSector Rank
Dividend Yield N/A

DOCEBO INC

TSX:DCBO (4/30/2025, 7:00:00 PM)

43.18

-0.58 (-1.33%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)02-28 2025-02-28/bmo
Earnings (Next)05-09 2025-05-09
Inst Owners35.68%
Inst Owner ChangeN/A
Ins Owners1.39%
Ins Owner ChangeN/A
Market Cap1.30B
Analysts81.43
Price Target49.51 (14.66%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)32.87%
Min EPS beat(2)-25.3%
Max EPS beat(2)91.05%
EPS beat(4)3
Avg EPS beat(4)24.07%
Min EPS beat(4)-25.3%
Max EPS beat(4)91.05%
EPS beat(8)6
Avg EPS beat(8)2.32%
EPS beat(12)9
Avg EPS beat(12)124.54%
EPS beat(16)11
Avg EPS beat(16)78.48%
Revenue beat(2)1
Avg Revenue beat(2)-0.07%
Min Revenue beat(2)-0.51%
Max Revenue beat(2)0.37%
Revenue beat(4)1
Avg Revenue beat(4)-0.53%
Min Revenue beat(4)-1.42%
Max Revenue beat(4)0.37%
Revenue beat(8)1
Avg Revenue beat(8)-0.74%
Revenue beat(12)1
Avg Revenue beat(12)-1.13%
Revenue beat(16)4
Avg Revenue beat(16)-0.06%
PT rev (1m)-7.28%
PT rev (3m)-12.17%
EPS NQ rev (1m)1.2%
EPS NQ rev (3m)3.28%
EPS NY rev (1m)-6.77%
EPS NY rev (3m)24.14%
Revenue NQ rev (1m)0.02%
Revenue NQ rev (3m)-2.18%
Revenue NY rev (1m)-0.31%
Revenue NY rev (3m)-2.19%
Valuation
Industry RankSector Rank
PE 36.29
Fwd PE 26.02
P/S 4.32
P/FCF 33.45
P/OCF 32.03
P/B 16.22
P/tB 22.18
EV/EBITDA 37.94
EPS(TTM)1.19
EY2.76%
EPS(NY)1.66
Fwd EY3.84%
FCF(TTM)1.29
FCFY2.99%
OCF(TTM)1.35
OCFY3.12%
SpS10
BVpS2.66
TBVpS1.95
PEG (NY)0.92
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 14.02%
ROE 46.29%
ROCE 30.44%
ROIC 17.84%
ROICexc N/A
ROICexgc N/A
OM 8.72%
PM (TTM) 12.32%
GM 80.96%
FCFM 12.91%
ROA(3y)6.1%
ROA(5y)2.04%
ROE(3y)18.51%
ROE(5y)8.92%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.38%
GM growth 5Y0.22%
F-Score7
Asset Turnover1.14
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0.05
Debt/EBITDA 0.01
Cap/Depr 36.79%
Cap/Sales 0.57%
Interest Coverage 250
Cash Conversion 131.21%
Profit Quality 104.74%
Current Ratio 1.2
Quick Ratio 1.2
Altman-Z 4.35
F-Score7
WACC9.26%
ROIC/WACC1.93
Cap/Depr(3y)34.45%
Cap/Depr(5y)55.59%
Cap/Sales(3y)0.56%
Cap/Sales(5y)1.02%
Profit Quality(3y)220.57%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)855.56%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%280%
EPS Next Y39.51%
EPS Next 2Y29.84%
EPS Next 3Y21.71%
EPS Next 5Y27.76%
Revenue 1Y (TTM)19.96%
Revenue growth 3Y27.67%
Revenue growth 5Y39.25%
Sales Q2Q%15.75%
Revenue Next Year11.76%
Revenue Next 2Y12.58%
Revenue Next 3Y25.18%
Revenue Next 5Y24.94%
EBIT growth 1Y2680.44%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year136.07%
EBIT Next 3Y58.04%
EBIT Next 5Y42.64%
FCF growth 1Y82.69%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y83.22%
OCF growth 3YN/A
OCF growth 5YN/A